Document is current
Any future updates will be listed below
-
Authors
d’Oleire Uquillas, Federico
Sefik, Esra https://orcid.org/0000-0002-5200-413X
Li, Bing https://orcid.org/0009-0007-5960-4537
Trotter, Matthew A.
Steele, Kara A.
Seidlitz, Jakob https://orcid.org/0000-0002-8164-7476
Gesue, Rowen
Latif, Mariam
Fasulo, Tristano
Zhang, Veronica https://orcid.org/0000-0001-8882-2102
Kislin, Mikhail https://orcid.org/0000-0002-5447-8881
Verpeut, Jessica L. https://orcid.org/0000-0003-2941-7697
Cohen, Jonathan D.
Sepulcre, Jorge https://orcid.org/0000-0002-4199-2304
Wang, Samuel S.-H.
Gomez, Jesse
-
Funding
Funding for this research was provided by:
National Academies of Sciences, Engineering, and Medicine
U.S. Department of Health & Human Services | National Institutes of Health (NS045193)
- License Information
-
More Information
Article History
Received: 12 December 2023
Revised: 23 September 2024
Accepted: 25 September 2024
First Online: 11 October 2024
Competing interests
: JS is a director of and holds equity in Centile Bioscience Inc.
: Informed consent or assent was obtained from all participants in accordance with Institutional Review Board oversight and from their legally authorized representative body. All study protocols were approved by the local institutional review board respective to each study site. Detailed ethics approval protocols are publicly available (https://fcon_1000.projects.nitrc.org/indi/abide/).
